Subsequently, the activated HIF-1α will translocate into the nucleus and form a heterodimer with HIF-1β to transactivate the transcription of target genes involved in tumor survival, metastasis, and angiogenesis, including vascular endothelial growth factor (VEGF) [5]. The gene discussed is HIF1A; the disease is neoplasm.